AI Insight
This study reveals the molecular mechanism by which DELE1, a mitochondrial stress sensor, activates the HRI kinase to trigger cellular stress responses. Using biophysical techniques and mass spectrometry, researchers demonstrated that when mitochondria are damaged, a fragment of DELE1 binds to HRI at the same site where haem normally binds, displacing the haem molecule and activating the kinase. This activation triggers the integrated stress response, a cellular defense mechanism important for mitochondrial quality control and neuronal health.
Why it matters
Understanding this activation mechanism could lead to therapeutic strategies for diseases involving mitochondrial dysfunction, including neurodegenerative disorders. The findings provide molecular targets for drugs that could modulate cellular stress responses in conditions where mitochondrial health is compromised.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Haem-Regulated Inhibitor (HRI, aka EIF2AK1) is one of four stress-sensing kinases that phosphorylate eIF2 as part of the integrated stress response (ISR). HRI was first characterized as a haem-sensing kinase where it is inhibited when bound to haem. Recent studies have revealed another role for HRI in sensing mitochondrial stress via the mitochondrial protein DELE1. Upon stress, DELE1 is cleaved, and its C-terminal fragment (DELE1CTD) is released from the mitochondria to the cytoplasm, where it interacts with HRI, to trigger the ISR. This pathway is critical for mitochondrial quality control and neuronal health. Here, we perform biophysical analysis to demonstrate that purified recombinant DELE1CTD binds with high affinity to the N-terminal region of HRI, competing with and displacing haem to activate HRI and pointing to a shared binding site. Using Hydrogen Deuterium Exchange Mass Spectrometry (HDX-MS), we map the binding footprint of DELE1CTD on HRI and confirm that it overlaps with the haem-binding site. These findings support a simple activation mechanism: DELE1CTD activates HRI by excluding inhibitory haem from its binding site.
Source: Structural Basis for Activation of HRI by the DELE1 C-terminal domain